Kyverna therapeutics to host virtual kol event to highlight neuroimmunology car t franchise

Webcast to be held august 28, 2025, 11:00am et emeryville, calif. , july 29, 2025 /prnewswire/ -- kyverna therapeutics, inc. (kyverna, nasdaq: kytx), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that the company will host a webcast event with key opinion leaders (kols) to discuss its neuroimmunology franchise.
KYTX Ratings Summary
KYTX Quant Ranking